Pages
Products
Luc/GFP Reporter Cell Line-B16F10

Luc/GFP Reporter Cell Line-B16F10

Cat.No. :  CSC-RR0231 Host Cell:  B16F10

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Documents

Cat. No. CSC-RR0231
Description Luc/GFP Reporter Cell Line-B16F10 is engineered to stably co-express GFP and luciferase reporter genes It is an ideal positive control for use in bioluminescence and fluorescence assays. In addition, B16F10 cells can form metastases in mouse lungs. The in vivo growth of metastases can be monitored using bioluminescent imaging or optical imaging for GFP fluorescence.
Background The Luc/GFP reporter cell line-B16F10 has emerged as a pivotal tool in biomedical research
Gene Luciferase/GFP
Host Cell B16F10
Host Cell Species Mus musculus (Mouse)
Stability Validated for at least 10 passages
Reporter Type Fluorescent protein
Application

1. Gene expression studies

2. Protein localization

3. Drug screening and toxicology

4. Live cell imaging

Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Shipping Dry ice
Storage Liquid nitrogen
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Quick Inquiry

Case Study

Applications

Publications

Q & A

Customer Reviews

Macrophages play a pivotal role in regulating inflammation and can either promote or inhibit tumor growth and metastasis. Researchers harnessed the anti-tumor potential of macrophages using Ferumoxytol (FMT) combined with the Toll-like receptor 3 (TLR3) agonist, poly (I:C) (PIC), or FP-NPs (nanoparticles composed of FMT-NH2 surface functionalized with PIC). In vitro studies revealed that these combinations synergistically inhibited B16F10 cell proliferation by inducing a tumoricidal macrophage phenotype with increased TNF-α and iNOS expression, enhanced NO secretion, and augmented phagocytosis. In vivo experiments demonstrated regression of primary melanoma and alleviation of pulmonary metastasis with elevated pro-inflammatory macrophage infiltration and upregulation of pro-inflammatory genes. FP-NPs showed enhanced anti-metastatic efficacy by steering macrophages to M1 phenotype through NF-κB signaling.

The combined effects of FMT and PIC on macrophage activation and tumor growth inhibition were studied using Luc/GFP Reporter Cell Line-B16F10. Cell viability, GFP fluorescence intensity, proliferation, and gene expression were analyzed in co-culture experiments with RAW 264.7 cells. The results demonstrated the potential of the FMT/PIC combination in enhancing macrophage activation and inhibiting tumor growth, contributing to the understanding of immune responses in cancer therapy.Figure 1. The combined effects of FMT and PIC on macrophage activation and tumor growth inhibition were studied using Luc/GFP Reporter Cell Line-B16F10. Cell viability, GFP fluorescence intensity, proliferation, and gene expression were analyzed in co-culture experiments with RAW 264.7 cells. The results demonstrated the potential of the FMT/PIC combination in enhancing macrophage activation and inhibiting tumor growth, contributing to the understanding of immune responses in cancer therapy. (Zhao J, et al., 2018)

1. Tumor Microenvironment Studies: Assessing Luc/GFP Reporter Cell Line-B16F10 enables real-time tracking of tumor growth and metastasis in vivo. 2. Drug Efficacy Evaluation: Evaluate therapeutic interventions by monitoring luciferase activity and GFP expression post-treatment. 3. Immunotherapy Assessment: Investigate immune response dynamics through luciferase imaging, elucidating the efficacy of immunotherapeutic approaches. 4. Metastasis Research: Study metastatic progression by tracking Luc/GFP-labeled cancer cells in various organs, providing insights into metastatic mechanisms. 5. Angiogenesis Investigations: Analyze tumor angiogenesis using Luc/GFP-labeled cells to visualize neovascularization and assess anti-angiogenic therapies. 6. Microenvironment Manipulation: Manipulate tumor microenvironment components and track changes in luciferase activity and GFP expression, elucidating their impact on tumor progression. 7. Metastatic Niche Exploration: Explore pre-metastatic niche formation and colonization dynamics through luciferase imaging of Luc/GFP-labeled cancer cells. 8. Drug Delivery Studies: Assess targeted drug delivery strategies by monitoring luciferase activity and GFP expression in tumor cells following treatment administration.
Customer Q&As
What motivated the choice of B16F10 cells for establishing the luciferase/GFP reporter cell line?

A: B16F10 cells were chosen for establishing the luciferase/GFP reporter cell line due to their relevance to melanoma research and their well-characterized genetic background. Additionally, B16F10 cells exhibit high transfection efficiency, making them suitable for stable expression studies.

How was the stability and expression level of luciferase and GFP confirmed and sustained in the B16F10 reporter cell line?

A: The stability and expression level of luciferase and GFP in the B16F10 reporter cell line were confirmed and sustained through stable transfection techniques, antibiotic selection, and validation of expression using luciferase assays and fluorescence microscopy. Regular subculture and monitoring of luciferase activity and fluorescence intensity were employed to maintain stable expression levels.

Could you provide insights into the functional characterization of luciferase and GFP expression in the B16F10 reporter cell line, considering their responsiveness to regulatory elements and involvement in cellular processes?

A: Functional characterization of luciferase and GFP expression in the B16F10 reporter cell line involved assessing their responsiveness to regulatory elements by analyzing changes in luciferase activity and fluorescence intensity in response to stimuli. Additionally, their involvement in cellular processes such as gene regulation, signaling pathways, or drug response was investigated using appropriate assays and imaging techniques.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Dual Fluorescence Power

Dual fluorescence power! The Luc/GFP Reporter Cell Line in B16F10 cells illuminates research with both luciferase and GFP, offering a dynamic platform for tracking tumor growth and gene expression.

United Kingdom

08/31/2021

Consistent Brilliance

From studying metastasis to evaluating treatment responses, this cell line serves as an invaluable tool for understanding tumor biology and testing novel therapies. The Luc/GFP Reporter Cell Line consistently delivers bright signals, enabling precise monitoring and quantification of cellular events.

Germany

01/31/2022

Streamlined Experimentation

Streamlined experimentation! Its dual-reporter system simplifies data collection and interpretation, accelerating discoveries in cancer biology and therapeutics.

Germany

05/19/2021

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction